• Anlotinib Hydrochloride Suppresses Angiogenesis via Multi-Ki

  2026-05-25

  This study demonstrates that Anlotinib hydrochloride, a multi-target tyrosine kinase inhibitor, robustly inhibits angiogenesis by targeting VEGFR2, PDGFRβ, and FGFR1. The findings highlight its superior efficacy over other anti-angiogenic agents, supporting its utility in cancer research.

• Decoding MCL-1 Dependency: A-1210477 in Cancer Apoptosis Res

  2026-05-25

  Explore how MCL-1 inhibitor A-1210477 enables precise analysis of apoptosis induction in cancer cells. This in-depth guide bridges foundational science and advanced research workflows for targeting MCL-1 in cancer biology.

• Phosbind Biotin (SKU F4001): Reliable Phosphorylation Detect

  2026-05-24

  This article addresses real laboratory challenges in Western Blot detection of phosphorylated proteins, focusing on the application of Phos binding reagent (Phosbind) Biotin (SKU F4001) from APExBIO. Integrating scenario-driven Q&A, it demonstrates how the dinuclear metal complex phosphate binding mechanism of Phosbind Biotin offers reproducible, cost-effective, and sequence-independent solutions for protein phosphorylation analysis in biomedical research.

• Puromycin Dihydrochloride: Precision Selection & Translation

  2026-05-23

  Puromycin dihydrochloride empowers researchers with unmatched versatility for stable cell line selection and dynamic analysis of translational control. Its potent, rapid action as an aminonucleoside antibiotic unlocks robust workflows from basic maintenance to advanced ribosome function studies—backed by APExBIO quality and evidence-based protocols.

• Breast Cancer’s MCL-1 Dependence: Anti-Apoptotic Function Un

  2026-05-22

  Recent evidence shows that breast cancer cells rely on MCL-1 primarily for its canonical anti-apoptotic role, rather than non-apoptotic functions. This finding clarifies the mechanism behind the efficacy of selective MCL-1 inhibitors and informs targeted therapy strategies.

• Ruthenium Red: Benchmark Ca2+ Transport Inhibitor in Cell Si

  2026-05-22

  Ruthenium Red is the gold-standard Ca2+ transport inhibitor, enabling high-precision dissection of calcium signaling and mechanotransduction, particularly in cytoskeleton-dependent autophagy. This guide translates breakthrough findings and advanced workflows into actionable protocols and troubleshooting strategies for researchers seeking robust, reproducible results.

• Tariquidar (XR9576): Applied Strategies in Drug Resistance R

  2026-05-21

  Tariquidar (XR9576) empowers researchers to dissect P-glycoprotein-driven chemoresistance, particularly in high-viscosity tumor models. This article translates breakthrough mechanobiology findings into actionable protocols, workflow enhancements, and troubleshooting strategies for reproducible ABC transporter inhibition.

• Cisplatin in Translational Oncology: Mechanistic Leverage an

  2026-05-21

  Explore how mechanistic insights into Cisplatin (CDDP)—from DNA crosslinking to apoptotic signaling—are reshaping translational cancer research. Drawing on fresh evidence and APExBIO’s research-grade product, we deliver actionable strategies for experimental optimization, overcoming chemoresistance, and maximizing translational impact.

• Ellagic Acid: Precision Tool for CK2 Signaling and Senescenc

  2026-05-20

  Ellagic acid empowers researchers to dissect CK2-driven signaling, apoptosis, and oxidative stress in cancer biology with unmatched specificity. This guide details optimized experimental workflows, troubleshooting strategies, and the translational impact of AI-driven senolytic discovery, setting Ellagic acid apart for advanced cellular assays.

• Caspase-3/7 Inhibitor I: Precision Tools for Apoptosis Modul

  2026-05-20

  Caspase-3/7 Inhibitor I empowers researchers to dissect caspase-dependent apoptosis with unmatched selectivity and reversibility, enabling advanced workflow designs in both basic and translational studies. This guide translates recent mechanistic breakthroughs—like phase-specific apoptosis in mammary epithelium—into actionable protocols, troubleshooting strategies, and comparative insights that elevate experimental reliability.

• LY364947: Advancing Precision TGF-β Inhibition in EMT and Di

  2026-05-19

  Explore how LY364947, a potent TGF-β type I receptor kinase inhibitor, empowers researchers to dissect EMT, fibrosis, and retinal degeneration with unmatched selectivity. This article offers a unique, evidence-based guide to experimental optimization and translational insight.

• Biotin-16-UTP: Practical Guide for RNA Labeling Workflows

  2026-05-19

  Biotin-16-UTP addresses specific challenges in RNA detection and purification by enabling efficient incorporation of biotin labels during in vitro transcription. It is best suited for workflows requiring high-affinity capture or detection of RNA, but is not recommended for diagnostic or therapeutic applications. Researchers should be mindful of stability and purity considerations to ensure optimal results.

• Practical Guide: HyperPFU™ High-Fidelity DNA Polymerase in P

  2026-05-18

  HyperPFU™ high-fidelity DNA polymerase addresses technical bottlenecks in PCR amplification of long, GC-rich, or otherwise challenging DNA templates, where standard enzymes often fail due to low fidelity or poor processivity. It is best suited for workflows requiring highly accurate, blunt-ended DNA products and should not be used in protocols that require 3'-A overhangs or sticky-end ligation.

• MCL-1’s Canonical Anti-Apoptotic Role in Breast Cancer Survi

  2026-05-18

  This study demonstrates that breast cancer cells are critically dependent on the canonical anti-apoptotic function of MCL-1 for survival. Genetic deletion or selective inhibition of MCL-1 induced tumor regression, implicating mitochondrial apoptosis as the primary vulnerability exploitable by MCL-1 inhibitors in breast cancer research.

• SEMA3E Regulates Beige Adipocyte Differentiation via β-caten

  2026-05-17

  This study uncovers SEMA3E as a key driver of beige adipocyte differentiation and thermogenesis in mice, acting through β-catenin signaling. The findings provide mechanistic insight into adipose tissue browning, with implications for metabolic and type II diabetes research.

16247 records 4/1084 page Previous Next 12345 下5页 Last page